Immunomodulatory Receptor ILT3/LILRB4 Protects Human Leukemic B Cells From Ferroptosis In Vitro. Drago R, Prete RD, Bartolini G, Gazziero VA, et al. Eur J Immunol 2026;56:e70289.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Drago R, Prete RD, Bartolini G, Gazziero VA, et al. Immunomodulatory Receptor ILT3/LILRB4 Protects Human Leukemic B Cells From Ferroptosis In Vitro. Eur J Immunol 2026;56:e70289.
PMID: 42847431